The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Denosumab biosimilar (LY01011) in the treatment of bone metastases in patients with solid tumors: A multicenter, randomized, double-blind, active comparator-controlled phase 3 study.
 
Mingchuan Zhao
No Relationships to Disclose
 
Xichun Hu
Honoraria - AstraZeneca; Daiichi Sankyo/Lilly; Eisai; Hengrui Pharmaceutical; Lilly; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca
 
Aiping Zeng
No Relationships to Disclose
 
Yan Yu
No Relationships to Disclose
 
Huaqiu Shi
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Hongmei Sun
No Relationships to Disclose
 
Weihua Yang
No Relationships to Disclose
 
Lili Sheng
No Relationships to Disclose
 
Peijian Peng
No Relationships to Disclose
 
Jingfen Wang
No Relationships to Disclose
 
Tienan Yi
No Relationships to Disclose
 
Minghong Bi
No Relationships to Disclose
 
Mingli Ni
No Relationships to Disclose
 
Xiumei Dai
No Relationships to Disclose
 
Changlu Hu
No Relationships to Disclose
 
Kaijian Lei
No Relationships to Disclose
 
Xia Yuan
No Relationships to Disclose
 
Qingshan Li
No Relationships to Disclose
 
Dongqing Lv
No Relationships to Disclose